Palimpsest Bio Corp. filed a Form D with the Securities and Exchange Commission on 2026-10-30.
Palimpsest Bio Corp. filed a Form D notice of an exempt securities offering with the SEC on October 30, 2026. The filing reports $172K sold. Its industry group is Biotechnology. It names Matthew Korpela (Executive Officer, Director) (SEC Form D, October 30, 2026).
Selling to Palimpsest Bio Corp.? See who runs it and how to reach them, plus this week's 44 other newly funded companies.
Is this your company?
Sell to companies like Palimpsest Bio Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Palimpsest Bio Corp.
Free to see. No signup.
More on the people and the money behind Palimpsest Bio Corp., from the filings we hold.
Biotechnology raises by companies based in Nevada, filed within 90 days of this one, largest first.
Get an email when Palimpsest Bio Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Palimpsest Bio Corp. raises, hires or launches. No email unless you switch it on.
Watch Palimpsest Bio Corp. →Get the full cited report on Palimpsest Bio Corp.
What the filing shows about Palimpsest Bio Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Palimpsest Bio Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Palimpsest Bio Corp.'s address as 4525 Dean Martin Dr., #2006, Las Vegas, NV 89103.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Palimpsest Bio Corp. is a registered filer with the SEC (CIK 2162952) and has filed since 2026-10-30. 1 filing is on record, the latest on 2026-10-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Palimpsest Bio Corp.'s Form D of 2026-10-30 names Matthew Korpela as its officers, directors or promoters.
Its new offerings report $172K sold across 1 offering, as its own filings state.
Trailing twelve months. 769 filings in Biotechnology, totalled by week. The dot is this raise, $172K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Matthew Korpela is named as Executive Officer and Director on the Form D that Palimpsest Bio Corp. filed with the SEC on 30 October 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-10-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Palimpsest Bio Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Palimpsest Bio Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Palimpsest Bio Corp. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Palimpsest Bio Corp.You get an alert in MentionFox the next time this company shows up.
If you're behind Palimpsest Bio Corp.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Palimpsest Bio Corp.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-10-26 · Biotech raises in Las Vegas
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/palimpsest-bio-corp-form-d-000001